Healthcare -
Biotechnology - NASDAQ - US
$ 1.985
5.59 %
$ 561 M
Market Cap
-2.51
P/E
ERAS - CASH & EQUIVALENTS
Cash & Equivalents ERAS - Erasca, Inc.
93.1 M
LAST VALUE
-49.19%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR